TY - JOUR T1 - Update on the management of venous thromboembolism JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 39 LP - 46 DO - 10.3949/ccjm.84.s3.04 VL - 84 IS - 12 suppl 3 AU - John R. Bartholomew Y1 - 2017/12/01 UR - http://www.ccjm.org/content/84/12_suppl_3/39.abstract N2 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disease associated with significant morbidity ranging from painful leg swelling, chest pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic pulmonary hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines. ER -